We will compensate researchers fairly as well.
Scientists and researchers can submit models and tools directly to superbio.ai. Anyone can run machine learning even if they are not a programmer and we have biology specific tools specifically for the biologists. By implementing in the cloud we can also optimize computation costs. We really want to accelerate machine learning for biologists – both in the implementation and in the running of experiments.
RONJON NAG HOW TO
I spent significant time teaching myself how to code, I worked as a robotics engineer, machine learning engineer, lab automation engineer before I said “Enough! Why are there no software tools to help me do my work?” And that’s how my Superbio.ai journey began.īoth: Superbio.ai is a cloud based platform to implement AI for biology with no code. I worked as a wet lab scientist and conducted neurosurgeries on rats to understand pathways of sensory shutdown. With an amazing group of students from Brown and Rhode Island School of Design, we designed award-winning medical devices. I was more of a traditional biomedical engineer. I received both Bachelor’s and Master’s degrees from Brown University in biomedical engineering. In 2021, I received both the IEEE-SCV Outstanding Engineer Award and the IEEE-USA Entrepreneur Achievement Award.īerke: My resume is only slightly shorter than Ronjon’s. I received the Institution of Engineering and Technology Mountbatten Medal. I have deployed AI systems for 30 years, having founded, advised, and sold companies to Motorola, BlackBerry, and Apple. I currently teach artificial intelligence, longevity science and technology, and healthcare venture capital at Stanford. I am also the Chairman of Superbio.ai, the startup that Berke founded in 2021. I’m also Founder of R42 Group, which invests in AI, biotech and science, and wireless communication technologies, and works with pre-seed startup. Ronjon Nag, and I am an inventor and Adjunct Professor in Genetics at Stanford University School of Medicine. Before we dig in, please tell us about your backgrounds.
RONJON NAG SERIES
In the spirit of honoring entrepreneurs who dare to launch businesses with an original mindset, we’re delighted to launch our Spotlight Series on emerging companies by showcasing Superbio.ai and its co-founders, Berke Buyukkucak and Ronjon Nag. It’s hard to imagine, but the greatest companies, Google, Microsoft, and Apple, were founded by just two inspired people with a vision to change the world. How can you ensure your new technology is attractive to investors throughout the entire process? Listen to this week’s episode to learn more.Ronjon Nag (left) and Berke Buyukkucak (right) Tetra Partner Network Spotlight Series
Can this challenge be mitigated? Funding is vital throughout a company or product life cycle, not just at the beginning. Based on risk, a company’s needs begin to change and develop, but at an early stage, with a lack of data or experience, it will be difficult to make these decisions. Over the life cycle of a company there will be different requirements and teams may need to reconfigure, adjust and grow. In this episode, we continued the conversation with Ronjon and Martin on what comes next: how you can build your team and scale up or expand once you’ve seen real patient benefits, and what comes at the end of the journey. In the last episode we discussed the different types of funding, what investors are looking for, and what developers should understand to attract investment. Evidencing long-term value to funders as well as patients and clinicians.
0 kommentar(er)
